{"id":"NCT01560403","sponsor":"Shire","briefTitle":"A One-Year, Open-Label Study With Teduglutide for Subjects Who Completed Study CL0600-021","officialTitle":"A One-Year, Open-Label Study With Teduglutide for Subjects With Parenteral Nutrition-dependent Short Bowel Syndrome Who Completed Study CL0600-021","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-05-21","primaryCompletion":"2013-07-23","completion":"2013-07-23","firstPosted":"2012-03-22","resultsPosted":"2014-12-25","lastUpdate":"2021-06-10"},"enrollment":14,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Short Bowel Syndrome"],"interventions":[{"type":"DRUG","name":"Teduglutide","otherNames":["Gattex"]}],"arms":[{"label":"Teduglutide","type":"EXPERIMENTAL"}],"summary":"This study is a 1-year open label extension study to collect long term efficacy and safety data from patients who have completed approximately 2 years of dosing in Study CL0600-021.","primaryOutcome":{"measure":"Summary of Treatment-emergent Adverse Events","timeFrame":"12 months","effectByArm":[{"arm":"NT,PBO/TED","deltaMin":4,"sd":null},{"arm":"TED/TED","deltaMin":5,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":1},"locations":{"siteCount":5,"countries":["United States"]},"refs":{"pmids":["29761915"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":9},"commonTop":["Asthenic conditions","Diarrhoea","Abdominal pain","Anxiety symptoms","Benign neoplasms gastrointestinal"]}}